Epic Sciences

📍 San Diego, United States🗓 Founded 2008👥 127 employees💰 Last funded Jun 2018
Biotechnology Research🌐 epicsciences.com
Website LinkedIn
Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer. Epic’s mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient’s journey. The company was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Our technology helps match patients to targeted therapies and monitor for drug resistance, so that the best treatment path can be chosen at every clinical decision point. Today, we partner with leading pharmaceutical companies and major cancer centers around the world. Epic’s goal is to commercialize our technology to increase the success rate of cancer drugs in clinical trials and improve patient outcomes by providing physicians with real-time information to guide treatment choices. For more information please contact us at info@epicsciences.com
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Epic Sciences?
Epic Sciences has 2 investors on record on gritt.io and 1 late-stage investors.
When did Epic Sciences last raise funding?
The most recent investment in Epic Sciences recorded on gritt.io was in June 2018.
When was Epic Sciences founded?
Epic Sciences was founded in 2008.
What industry is Epic Sciences in?
Epic Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Epic Sciences based?
Epic Sciences is headquartered in San Diego, United States.